ClinicalTrials.gg
TerminatedNCT06152081Updated Nov 9, 2026

Caries Detection With Two Different Caries Detecting Devices

An interventional study of LumiCare rinse and QLF Inspektor Pro Imaging in Caries,Dental, sponsored by Tufts University. Terminated at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Tufts University · Not applicable, Interventional, and Diagnostic

How we know

Why this study was terminated
insufficient recruitment and funding
Updated Nov 9, 2026Now TerminatedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 194 studies in Dental Caries with a site in United States — 17 open to participants now, 20 under way, 3 of them phase 3. Dental Caries · United States.

Enrollment
167th of 169
1 · median 60
Started
2025
with 7 others
No phase
111 of 194
14 open now
Registered
163rd of 194
by date

Among the 194 studies in Dental Caries with a site in United States, this one is the 167th largest by enrollment of the 169 interventional ones that give a count, is one of 8 that started in 2025, is one of 111 with no phase, and was the 163rd registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

17 of the 194 studies in Dental Caries with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 21 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 194 studies in Dental Caries with a site in United States, or all of them as a file.
02

Study summary

The primary aim of this study will be to compare the effectiveness of the novel LumiCare™ rinse and with QLF in determining caries progression. The secondary aim is to compare the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not.

03

Conditions studied

  • Caries,Dental

Browse trials for

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of TUSDM Comprehensive Care Clinic
  • Adult patients over the age of 21
  • Extreme/High Caries Risk classification per TUSDM Caries Management by Risk Assessment (CAMBRA) form
  • Presence of 2 or more initial active primary carious lesions on a free coronal surface of any tooth by visual assessment, QLF, and LumiCare™
  • Presence of at least 1 cavitated lesion
  • Updated (no more than 6 months old) bite wing radiographs available.
  • Patients who responded either yes/no to use of e-cigarettes/vapes
  • 1 active caries, 1 inactive caries and 1 sound tooth surface.

Exclusion criteria

Exclusion Criteria:

  • Low or moderate caries risk classification per TUSDM CAMBRA form
  • No clinically detectable carious lesions on free coronal surfaces
  • No cavitated caries lesions
  • Carious teeth with caries lesions concomitant with extrinsic stains, fluorosis, or developmental defects.
  • Patients who responded yes to the use of conventional cigarettes or smokeless tobacco
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1 participant (actual)

Study arms

  • Experimental
    All Participants

    All participants enrolled in the study will have the two caries detecting devices used during each research visit.

    Device: LumiCare rinse · Device: QLF Inspektor Pro Imaging

Interventions

  • DeviceLumiCare rinse

    The teeth being assessed will be cleaned of any debris ,plaque and calculus. The areas being assessed will be air dried. A dry field will be maintained using cotton rolls and a saliva ejector. Lumicare rinse will be applied onto the test areas for 30 seconds and the excess removed using a saliva ejector. The sites will then be rinsed with plain water for 10 seconds and excess will be removed using high volume suction. A blue curing light will then be held 1-2 inches from the test surfaces while the examiner assesses the surfaces for the presence or absence of fluorescent illumination.

  • DeviceQLF Inspektor Pro Imaging

    The teeth being assessed will be cleaned of any debris ,plaque and calculus. The areas being assessed will be air dried. A dry field will be maintained using cotton rolls and a saliva ejector. The QLF device will be positioned over the tooth surface to be tested and an image will be taken. The images will be stored automatically and assessed by the examiners for the presence of green fluorescence using the QA2 program (Version 1.25, Inspektor Research systems BV, Amsterdam, The Netherlands) . The trend in green fluorescence will also be calculated using this software algorithm.

06

What researchers measure

Primary outcomes

  1. Comparison of two caries-detecting devices

    Compare the effectiveness of the two caries detecting devices in their ability determining caries progression

    Time frame: 12 months

Secondary outcomes

  1. Caries progression in those who do and do not use e-cigarettes/vapes

    Comparison of the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not

    Time frame: 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Apr 2025 to primary completion in Jun 2026, 14 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Apr 2026 → Jun 2026 and completion Oct 2027 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2023
First posted
Nov 30, 2023
StartActual
Apr 1, 2025
Primary completionActual
Jun 6, 2026was Apr 2026
CompletionActual
Jun 6, 2026was Oct 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Terminated insufficient recruitment and funding
changed Nov 9, 2026
Primary completion
Apr 2026→Jun 6, 2026 (actual)
Nov 9, 2026
Study completion
Oct 2027→Jun 6, 2026 (actual)
Nov 9, 2026
Enrollment
60 (estimated)→1 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Recruiting→Terminated
    Why stopped insufficient recruitment and funding
    Primary completion Apr 2026→Jun 6, 2026 (now actual)
    Study completion Oct 2027→Jun 6, 2026 (now actual)
    Enrollment 60 (estimated)→1 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06152081
Lead sponsor
Tufts University
Responsible party
Sponsor
First posted
Nov 30, 2023
Start date
Apr 1, 2025
Primary completion
Jun 6, 2026
Completion
Jun 6, 2026
Last update
Nov 9, 2026

Study contacts

Karina Irusa, BDS, MS
principal investigator · Tufts University School of Dental Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion